⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001921607

OELKE MATHIAS

Reports to the SEC for 1 company · GAITHERSBURG, MD

Transactions

19

Companies

1

Filings

3

CIK

0001921607

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+81.1K sh	—	—	81,100
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−60K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+21.3K sh	—	—	21,250
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+38.8K sh	—	—	38,750
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−19.9K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+12.9K sh	—	—	12,855
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+7,050 sh	—	—	7,050
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−31.9K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+31.9K sh	—	—	31,948
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−4,755 sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+4,755 sh	—	—	4,755
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−115K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+115K sh	—	—	115,051
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−47.4K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+47.4K sh	—	—	47,379
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−15.8K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Chief Science Officer	AAward	+15.8K sh	—	—	15,793
2022-11-22	NexImmune, Inc.A Award	Chief Science Officer	AAward	+126K sh	—	—	134,023
2022-04-05	NexImmune, Inc.Stock Option (Right to Buy)A Award	Chief Science Officer	AAward	+60K sh	—	—	60,000

Recent filings

3

Accepted (ET)
Apr 64
OELKE MATHIAS0001209191-23-023687
SEC(opens sec.gov)
Nov 254
OELKE MATHIAS0001209191-22-058800
SEC(opens sec.gov)
Apr 74
OELKE MATHIAS0001209191-22-023749
SEC(opens sec.gov)

Companies

1

NexImmune, Inc.Chief Science Officer

Address

C/O NEXIMMUNE, INC. 9119 GATHER ROAD

GAITHERSBURG, MD, 20877